New Owner
Sankyo Pharmaceuticals - Ambit Biosciences
Sankyo Pharmaceuticals acquires Ambit Biosciences
Announced: September 29, 2014
Type: Acquisition
Disposition: Combined
Terms: Cash & Stock
Status: Complete
Amount: $ 410,000,000
